PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
28.40%
Positive revenue growth while OBE is negative. John Neff might see a notable competitive edge here.
81.45%
Positive gross profit growth while OBE is negative. John Neff would see a clear operational edge over the competitor.
60.76%
EBIT growth 50-75% of OBE's 84.00%. Martin Whitman would suspect suboptimal resource allocation.
60.76%
Positive operating income growth while OBE is negative. John Neff might view this as a competitive edge in operations.
59.63%
Net income growth at 50-75% of OBE's 107.50%. Martin Whitman would question fundamental disadvantages in expenses or demand.
59.49%
EPS growth at 50-75% of OBE's 107.54%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
59.66%
Diluted EPS growth at 50-75% of OBE's 107.54%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
-0.28%
Share reduction while OBE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
0.28%
Dividend growth of 0.28% while OBE is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
45.84%
Positive OCF growth while OBE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
164.79%
Positive FCF growth while OBE is negative. John Neff would see a strong competitive edge in net cash generation.
-39.31%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-3.54%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-5.17%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-55.53%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
4.46%
Positive OCF/share growth while OBE is negative. John Neff might see a comparative advantage in operational cash viability.
46.32%
3Y OCF/share CAGR 1.25-1.5x OBE's 39.67%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
-730.97%
Negative 10Y net income/share CAGR while OBE is at 101.26%. Joel Greenblatt sees a major red flag in long-term profit erosion.
34.70%
Below 50% of OBE's 100.02%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-101.34%
Negative 3Y CAGR while OBE is 100.49%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-87.41%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-59.50%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-57.18%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-90.72%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-59.95%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
28.73%
3Y dividend/share CAGR of 28.73% while OBE is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-14.75%
Firm’s AR is declining while OBE shows 13.33%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-4.54%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-11.59%
We have a declining book value while OBE shows 0.34%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-1.95%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-77.70%
We cut SG&A while OBE invests at 0.91%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.